We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Pharmacological treatment for cardiovascular disease during pregnancy and lactation.
Journal of Cardiology 2019 May
Maternal circulatory dynamics change drastically during pregnancy and delivery. Therefore, pregnancy with concomitant cardiovascular disease has risks, even for maternal death, in severe cases. This condition has tended to increase with advances in medical care and an increase in the age of pregnant women. Drug therapy during pregnancy and lactation should be administered if it is judged that this is necessary to improve the maternal pathology despite a risk of adverse effects. Fetuses and infants are exposed to maternal drugs, which is a specific concern in drug therapy for pregnant and lactating women. Care is needed because of the risk of adverse effects of teratogenicity in the organogenesis period and fetal toxicity thereafter. However, unstable maternal circulatory dynamics also inhibit fetal development and increase the risk of premature delivery, and stabilization of maternal physiologic condition by drug therapy often gives benefit to fetuses indirectly. Therefore, detailed knowledge of drug therapy during pregnancy should be acquired to manage the condition appropriately. Caution is also needed in using some obstetric drugs, such as tocolytic agents, which influence maternal circulatory dynamics. Therefore, drug therapy during pregnancy and lactation should only be used after full consideration of its benefit and possible harm to the mother and child, and after obtaining consent from the patient after giving a sufficient explanation. In this report, we review drug therapy for pregnant and lactating women with concomitant cardiovascular disease.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app